RESCUE OF HIPPO CO-ACTIVATOR YAP1 TRIGGERS DNA DAMAGE-INDUCED APOPTOSIS IN HEMATOLOGICAL CANCERS
Hacken, Elisa ten
Bertilaccio, Maria Teresa
Kuehl, W. Michael
Tonon, GiovanniNote: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationCottini, F., T. Hideshima, C. Xu, M. Sattler, M. Dori, L. Agnelli, E. t. Hacken, et al. 2014. “RESCUE OF HIPPO CO-ACTIVATOR YAP1 TRIGGERS DNA DAMAGE-INDUCED APOPTOSIS IN HEMATOLOGICAL CANCERS.” Nature medicine 20 (6): 599-606. doi:10.1038/nm.3562. http://dx.doi.org/10.1038/nm.3562.
AbstractOncogene–induced DNA damage elicits genomic instability in epithelial cancer cells, but apoptosis is blocked through inactivation of the tumor suppressor p53. In hematological cancers, the relevance of ongoing DNA damage and mechanisms by which apoptosis is suppressed are largely unknown. We found pervasive DNA damage in hematologic malignancies including multiple myeloma, lymphoma and leukemia, which leads to activation of a p53–independent, pro-apoptotic network centered on nuclear relocalization of ABL1 kinase. Although nuclear ABL1 triggers cell death through its interaction with the Hippo pathway co–activator YAP1 in normal cells, we show that low YAP1 levels prevent nuclear ABL1–induced apoptosis in these hematologic malignancies. YAP1 is under the control of a serine–threonine kinase, STK4. Importantly, genetic inactivation of STK4 restores YAP1 levels, triggering cell death in vitro and in vivo. Our data therefore identify a novel synthetic–lethal strategy to selectively target cancer cells presenting with endogenous DNA damage and low YAP1 levels.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:13581189
- HMS Scholarly Articles